Works matching IS 14783223 AND DT 2018 AND VI 38 AND IP 11
Results: 25
Immune responses against tumour‐associated antigen‐derived cytotoxic T lymphocyte epitopes in cholangiocarcinoma patients.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2040, doi. 10.1111/liv.13885
- By:
- Publication type:
- Article
Bleeding after paracentesis in patients with decompensated cirrhosis and acute kidney injury: The perfect storm.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
In vitro efficacy of pro‐ and anticoagulant strategies in compensated and acutely ill patients with cirrhosis.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1988, doi. 10.1111/liv.13882
- By:
- Publication type:
- Article
Metabolic disorders across hepatocellular carcinoma in Italy.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2028, doi. 10.1111/liv.13877
- By:
- Publication type:
- Article
Leaving behind pegylated interferon‐based regimens to eliminate hepatitis C as a public health threat by 2030 as set out by WHO.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1902, doi. 10.1111/liv.13944
- By:
- Publication type:
- Article
Optimizing medication management for patients with cirrhosis: Evidence‐based strategies and their outcomes.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1882, doi. 10.1111/liv.13892
- By:
- Publication type:
- Article
A combination of the on‐treatment FIB‐4 and alpha‐foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1997, doi. 10.1111/liv.13889
- By:
- Publication type:
- Article
Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT1 patients.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1906, doi. 10.1111/liv.13932
- By:
- Publication type:
- Article
Territory‐wide population‐based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong Kong.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1911, doi. 10.1111/liv.13926
- By:
- Publication type:
- Article
Hepatorenal syndrome in the era of acute kidney injury.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1891, doi. 10.1111/liv.13893
- By:
- Publication type:
- Article
Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2018, doi. 10.1111/liv.13872
- By:
- Publication type:
- Article
Identifying palliative care needs in a Portuguese liver unit.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1982, doi. 10.1111/liv.13865
- By:
- Publication type:
- Article
Acute liver failure caused by hepatitis E virus genotype 3 and 4: A systematic review and pooled analysis.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1965, doi. 10.1111/liv.13861
- By:
- Publication type:
- Article
Nonalcoholic fatty liver disease is associated with decreased lung function.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2091, doi. 10.1111/liv.13860
- By:
- Publication type:
- Article
Hepatitis E seroprevalence in the Americas: A systematic review and meta‐analysis.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1951, doi. 10.1111/liv.13859
- By:
- Publication type:
- Article
Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1940, doi. 10.1111/liv.13858
- By:
- Publication type:
- Article
Sp1‐regulated transcription of RasGRP1 promotes hepatocellular carcinoma (HCC) proliferation.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2006, doi. 10.1111/liv.13757
- By:
- Publication type:
- Article
Development and validation of a novel score for fibrosis staging in patients with chronic hepatitis B.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1930, doi. 10.1111/liv.13756
- By:
- Publication type:
- Article
Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2082, doi. 10.1111/liv.13751
- By:
- Publication type:
- Article
Twenty‐five‐year trajectories of insulin resistance and pancreatic β‐cell response and diabetes risk in nonalcoholic fatty liver disease.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2069, doi. 10.1111/liv.13747
- By:
- Publication type:
- Article
Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2060, doi. 10.1111/liv.13743
- By:
- Publication type:
- Article
Pulmonary transit time derived from pulmonary angiography for the diagnosis of hepatopulmonary syndrome.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1974, doi. 10.1111/liv.13741
- By:
- Publication type:
- Article
Serum testosterone and non‐alcoholic fatty liver disease in men and women in the US.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 2051, doi. 10.1111/liv.13735
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1877, doi. 10.1111/liv.13579
- Publication type:
- Article
Serological responses to revaccination against HBV in HIV‐positive patients born in the era of nationwide neonatal HBV vaccination.
- Published in:
- Liver International, 2018, v. 38, n. 11, p. 1920, doi. 10.1111/liv.13721
- By:
- Publication type:
- Article